Curetech Formulations Private Limited

Curetech Formulations Private Limited - pharma in Shimla, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN U24232HP2003PTC026326 Incorporated 29 August 2003 ROC Himachal Pradesh HQ Shimla, Himachal Pradesh, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2024
₹83.74 Cr
▲ 4% YoY
Net profit · FY 2024
₹68.84 Lakh
Net margin 0.8%
EBITDA · FY 2024
₹3.92 Cr
EBITDA margin 4.7%
Authorised capital
₹16 Lakh
Registered with MCA
Paid-up capital
₹15.3 Lakh
Issued & subscribed
Open charges
₹30.1 Cr
Satisfied ₹18.11 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
405
Provident fund records

About Curetech Formulations Private Limited

Data last updated:

Curetech Formulations Private Limited is a private limited company based in Shimla, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24232HP2003PTC026326. Its GSTIN is 02AACCC4441N1ZU (Himachal Pradesh). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹16 Lakh and a paid-up capital of ₹15.3 Lakh. It is led by directors Sumit Kumar (Whole-Time Director) and Ashwani Kumar (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Vill Juddi Kalanjyothi Laboratories Baddi Distt Solan, Shimla, Himachal Pradesh, India – 171001.

As per the financials filed for FY 2024, the company reported a revenue of ₹83.74 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹68.84 Lakh (net margin 0.8%) and EBITDA of ₹3.92 Cr (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 11% over five years.

The company has about 405 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹30.1 Cr and satisfied charges of ₹18.11 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 2 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in December 2006. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Nava Healthcare Private Limited with revenue of ₹84.21 Cr.

Curetech Formulations Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0001739). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curetechformulations.com.

Company details

CIN U24232HP2003PTC026326
Registration Number 026326
Incorporation Date 29 August 2003
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0001739

Recognitions & Rankings of Curetech Formulations

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-HP-11-0001739

Contact details

Curetech Formulations Private Limited's registered office is in Shimla, Himachal Pradesh. Its website is curetechformulations.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Vill Juddi Kalanjyothi Laboratories Baddi Distt Solan, Shimla, Himachal Pradesh, India – 171001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Curetech Formulations Private Limited, buy the company report.

Comprehensive company report
Curetech Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Curetech Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Curetech Formulations Private Limited, buy the company report.

Financials of Curetech Formulations Private Limited

FY 2024 filings available

Curetech Formulations Private Limited reported revenue of ₹83.74 Cr (up 4% YoY) for FY 2024.

Revenue · FY 2024
₹83.74 Cr ▲ 4%
Net profit · FY 2024
₹68.84 Lakh margin 0.8%
EBITDA · FY 2024
₹3.92 Cr margin 4.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 19%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 10%
5 years · compounded
▲ 46%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 4% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹83.74 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.92 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹68.84 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin4.7%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Curetech Formulations Private Limited, buy the company report.

Board of directors of Curetech Formulations Private Limited

Curetech Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sumit KumarWhole-Time Director01 Aug 200620 Years 3 MonthsCurrent
Ashwani KumarWhole-Time Director29 Aug 200323 Years 2 MonthsCurrent

Peer comparison

Curetech Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Nava Healthcare Private Limited₹84.21 Cr (FY 2025)2.0%New Delhi, Delhi, India
Inchem Laboratories Private Limited₹84.08 Cr (FY 2025)12.0%Hyderabad, Telangana, India
Macmillon Pharmaceuticals Private Limited₹83.91 Cr (FY 2024)50.0%Punjab, India
Sunbeam Lifesciences Private Limited₹83.83 Cr (FY 2025)25.0%Puducherry, India
Curetech Formulations Private Limitedthis company₹83.74 Cr (FY 2024)₹68.84 Lakh0.8%4.0%405Shimla, Himachal Pradesh, India
Wexford Laboratories Private Limited₹83.63 Cr (FY 2024)22.0%Tumkur, Karnataka, India
J Duncan Healthcare Private Limited₹82.47 Cr (FY 2025)-57.0%Shahapur, Maharashtra, India
Maxheal Pharmaceuticals (India) Limited₹82.41 Cr (FY 2024)10.0%Mumbai, Maharashtra, India

To see the full peer comparison of Curetech Formulations Private Limited, buy the company report.

Auditor

Curetech Formulations Private Limited is audited by JAIN & ANIL SOOD for the financial year 2024.

Auditor firmFinancial yearFirm registration number
JAIN & ANIL SOODFY 2024010505N

Shareholding

The shareholding of Curetech Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Curetech Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹30.1 Cr
Satisfied charges
₹18.11 Cr
Breakdown by lending institutions
Others₹25.47 Cr
Hdfc Bank Limited₹2.91 Cr
Sidbi₹1.72 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Oct 2025101179234Others₹2 CrOpen
27 Aug 2025101151271Others₹96.9 LakhOpen
07 Jul 2025101127022Sidbi₹1.72 CrOpen
18 May 2024100940237Others₹9.5 LakhOpen
13 Feb 2024100872517Others₹3.25 CrOpen

To see the full charge records of Curetech Formulations Private Limited, buy the company report.

Total charge records: 26 View all charges

Deals & funding

Curetech Formulations Private Limited has 1 deal on record (1 secondary share transfer); the latest was in December 2006.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Dec 2006Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Curetech Formulations Private Limited was last rated by Brickwork on 13 Mar 2020.

Rating agencyRated onRating
Brickwork13 Mar 2020

To see the full credit ratings and regulatory alerts of Curetech Formulations Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Curetech Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Curetech Formulations Private Limited has a workforce of 405 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
405
Active EPFO establishments
2
Employee growth
-7.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27405
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Curetech Formulations Private Limited, buy the company report.

GST

Curetech Formulations has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
02AACCC4441N1ZUHimachal PradeshActive01 Jul 2017
02AACCC4441N2ZTHimachal PradeshActive14 Jul 2017

To see the full GST registrations and return filing status of Curetech Formulations Private Limited, buy the company report.

Recent activity

Curetech Formulations Private Limited has 4 board changes on record since 2003: 2 appointments and 2 cessations. The latest: Ashwani Kumar ceased to be Managing Director on 01 Dec 2015.

Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101179234 was registered on 17 Oct 2025.
Charges
A charge with Others of Rs. 1,800.00 Lakh registered on 18 Dec 2021 with Charge ID 100521480 was modified on 17 Oct 2025.
Charges
A charge with Others amounted to Rs. 96.90 Lakh with Charge ID 101151271 was registered on 27 Aug 2025.
Charges
A charge with Sidbi amounted to Rs. 172.00 Lakh with Charge ID 101127022 was registered on 07 Jul 2025.
Charges
A charge registered on 24 Jul 2017 via Charge ID 100116939 with Others was fully satisfied on 05 Nov 2024.
AGM
Curetech Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 290.90 Lakh registered on 19 May 2023 with Charge ID 100735337 was modified on 28 Jun 2024.
Charges
A charge registered on 31 Jul 2021 via Charge ID 100479014 with Hdfc Bank Limited was fully satisfied on 06 Jun 2024.
Charges
A charge with Others amounted to Rs. 9.50 Lakh with Charge ID 100940237 was registered on 18 May 2024.
Filing
Curetech Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh.
Charges
A charge registered on 10 Jun 2020 via Charge ID 100340315 with Others was fully satisfied on 12 Mar 2024.
Charges
A charge registered on 24 Jul 2017 via Charge ID 100116894 with Others was fully satisfied on 12 Mar 2024.

50 earlier events are in the company report.

Frequently asked questions

Curetech Formulations is an active private limited company based in Shimla, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2003 (23+ years old) and is registered under CIN U24232HP2003PTC026326.

Curetech Formulations has 2 current directors:

The latest financial statements of Curetech Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Curetech Formulations is 02AACCC4441N1ZU, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02AACCC4441N2ZT (Himachal Pradesh).

The CIN (Corporate Identification Number) of Curetech Formulations is U24232HP2003PTC026326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Curetech Formulations has 8 court cases on record: 4 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.

Curetech Formulations was incorporated on 29 August 2003, making it 23+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

Curetech Formulations has 1 deal on record (1 secondary share transfer); the latest was in December 2006.

The peers of Curetech Formulations by revenue are Nava Healthcare Private Limited, Inchem Laboratories Private Limited, Macmillon Pharmaceuticals Private Limited, Sunbeam Lifesciences Private Limited, Wexford Laboratories Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ashwani Kumar ceased to be Managing Director on 01 Dec 2015. Sumit Kumar ceased to be Director on 01 Dec 2015. Sumit Kumar was appointed as Whole-Time Director on 01 Aug 2006. Curetech Formulations has 4 board changes on record in total.

Yes, Curetech Formulations is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0001739).